These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2031438)

  • 41. Sex-based effects on the distribution of NK cell subsets in response to exercise and carbohydrate intake in adolescents.
    Timmons BW; Tarnopolsky MA; Bar-Or O
    J Appl Physiol (1985); 2006 May; 100(5):1513-9. PubMed ID: 16410379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High serum sex hormone-binding globulin (SHBG) and low serum non-SHBG-bound testosterone in boys with idiopathic hypopituitarism: effect of recombinant human growth hormone treatment.
    Belgorosky A; Martinez A; Domene H; Heinrich JJ; Bergada C; Rivarola MA
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1107-11. PubMed ID: 3680477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The behaviour of the peripheral natural killer cells in the foetal growth restriction.
    Vesce F; Cagnazzo E; Giugliano E; Mossuto E; Marci R
    Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2248-52. PubMed ID: 25219821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exercise and blood lymphocyte subset responses: intensity, duration, and subject fitness effects.
    Kendall A; Hoffman-Goetz L; Houston M; MacNeil B; Arumugam Y
    J Appl Physiol (1985); 1990 Jul; 69(1):251-60. PubMed ID: 2144268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feedback inhibition of gonadotropins by testosterone in men with hypogonadotropic hypogonadism: comparison to the intact pituitary-testicular axis in primary hypogonadism.
    Shimon I; Lubina A; Gorfine M; Ilany J
    J Androl; 2006; 27(3):358-64. PubMed ID: 16474013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men.
    Yaron M; Greenman Y; Rosenfeld JB; Izkhakov E; Limor R; Osher E; Shenkerman G; Tordjman K; Stern N
    Eur J Endocrinol; 2009 May; 160(5):839-46. PubMed ID: 19174534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
    Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].
    Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of long-term pulsatile GnRH administration on the 24-hour integrated concentration of GH in hypogonadotropic hypogonadic patients.
    Giusti M; Torre R; Cavagnaro P; Attanasio R; Traverso L; Giordano G
    Acta Endocrinol (Copenh); 1989 Jun; 120(6):724-8. PubMed ID: 2499152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
    Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gonadotropin treatment increases homocysteine levels in idiopathic hypogonadotropic hypogonadism: an indirect effect mediated by changes in body composition.
    Oktenli C; Yesilova Z; Ozata M; Yaman H; Tuzun A; Dundar S; Sanisoglu SY; Musabak U; Erbil MK; Dagalp K
    J Endocrinol; 2003 Oct; 179(1):35-9. PubMed ID: 14529563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymphocyte cAMP and ageing: significance of subset composition, plasma noradrenaline, regular physical training and long-term smoking.
    Knudsen JH; Gustafsson F; Toft J; Christensen NJ
    Clin Sci (Lond); 1996 Nov; 91(5):621-6. PubMed ID: 8942401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hypogonadism in idiopathic hemochromatosis].
    Foscolo G; De Menis E; Legovini P; Breda F; Monco A; Scaldaferri E; Conte N
    Minerva Endocrinol; 1989; 14(3):159-63. PubMed ID: 2516238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma ghrelin levels in males with idiopathic hypogonadotropic hypogonadism.
    Duran C; Yonem A; Ustun I; Ozcan O; Ipcioglu OM; Basekim CC
    Endocrine; 2008; 34(1-3):81-6. PubMed ID: 18946744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies of the pituitary-Leydig cell axis in young men with hypogonadotropic hypogonadism and hyposmia: comparison with normal men, prepuberal boys, and hypopituitary patients.
    Bardin CW; Ross GT; Rifkind AB; Cargille CM; Lipsett MB
    J Clin Invest; 1969 Nov; 48(11):2046-56. PubMed ID: 4390462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Testosterone replacement therapy in male hypogonadism is not associated with increase of endothelin-1 levels.
    Kumanov P; Tomova A; Kirilov G
    Int J Androl; 2007 Feb; 30(1):41-7. PubMed ID: 16879620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Congenital combined pituitary hormone deficiency patients have better responses to gonadotrophin-induced spermatogenesis than idiopathic hypogonadotropic hypogonadism patients.
    Mao J; Xu H; Wang X; Huang B; Liu Z; Zhen J; Nie M; Min L; Wu X
    Hum Reprod; 2015 Sep; 30(9):2031-7. PubMed ID: 26141714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Male hypogonadism with gynecomastia caused by late-onset deficiency of testicular 17-ketosteroid reductase.
    Castro-Magana M; Angulo M; Uy J
    N Engl J Med; 1993 May; 328(18):1297-301. PubMed ID: 8469252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Testosterone treatment alters melatonin concentrations in male patients with gonadotropin-releasing hormone deficiency.
    Luboshitzky R; Lavi S; Thuma I; Lavie P
    J Clin Endocrinol Metab; 1996 Feb; 81(2):770-4. PubMed ID: 8636302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.